Investors Land ALLO 22.8% Cheaper Than Its Secondary Stock Offering
August 15, 2024 at 17:09 PM EDT
Looking back to 94 days ago, Allogene Therapeutics Inc (ALLO) priced a 37,931,035 share secondary stock offering at $2.90 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..